Conditioned Medium Formulation Stabilization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The storage and delivery of conditioned media from mesenchymal stem cells are hindered by its liquid consistency, short shelf life, temperature instability, and protein denaturation, making it difficult to stabilize and effectively deliver for medical or cosmetic applications.
Innovation Solution
A formulation combining the conditioned medium with a diluent, chelator, humectant, preservative, emollient, and emulsifier is created to stabilize and facilitate topical delivery, enhancing the storage, transportation, and application of the medium.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conditioned medium is stored in liquid form, then it maintains bioactive properties, but it has short shelf life and temperature instability
Solution Approach 1:
The patent changes the physical state parameter of the conditioned medium from liquid to frozen form. Freezing the conditioned medium stabilizes it for long-term storage while preserving bioactive properties. The formulation includes cryoprotectants and specific buffer systems that prevent protein denaturation during freezing and thawing cycles, resolving the contradiction between maintaining bioactivity and extending shelf life.
Solution Approach 2:
The patent creates a composite storage formulation by combining conditioned medium with protective agents including cryoprotectants (such as glycerol or sucrose), buffers (such as HEPES or phosphate), and stabilizing proteins. This composite formulation provides both long-term stability during storage and preservation of bioactive properties upon thawing and application.
2Ease of operation
If conditioned medium is transported and stored, then it can be delivered to patients, but proteins denature over time
Solution Approach 1:
The patent applies preliminary protective measures by formulating the conditioned medium with stabilizing agents before storage and transport. The formulation includes reducing agents (such as DTT or beta-mercaptoethanol) that prevent oxidation, chelating agents that prevent metal-catalyzed degradation, and protective proteins that maintain structural integrity. These preliminary actions ensure protein stability throughout the transport and storage period.
Solution Approach 2:
The patent employs inert or controlled atmosphere packaging by excluding oxygen and introducing nitrogen or argon atmosphere during storage and transport. This prevents oxidative denaturation of proteins and maintains composition stability. The packaging system includes oxygen-scavenging materials and sealed containers that maintain the inert environment throughout the supply chain.
3Ease of manufacture
If conditioned medium is applied topically, then it provides wound healing benefits, but liquid consistency makes effective delivery difficult
Solution Approach 1:
The patent utilizes advanced delivery systems such as liposomal encapsulation, nanoparticle carriers, or hydrogel matrices that can be applied topically. These flexible delivery vehicles encapsulate the conditioned medium components, protecting them from degradation while enabling controlled release at the wound site. The thin film or gel formulation improves ease of topical application while maintaining therapeutic efficacy.
Data Source
AI summary
A method of creating a protein rich conditioned medium. The method includes culturing mesenchymal stem cells in a container utilizing a first growth medium, allowing a time period for proliferation of the mesenchymal stem cells until a desired level of confluence is achieved in the container, discarding a supernatant from the container, adding a second medium to the container, incubating the mesenchymal stem cells, and collecting the conditioned medium. The method produces significantly higher quantities of byproducts secreted by the mesenchymal stem cells. Byproducts are usable for wound healing, disease treatment, cosmetic, or other beneficial effects when applied or otherwise delivered to a patient.